# Akorn Operating Company LLC – FDA Inspection, May 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/akorn-operating-company-llc/7082c37e-d91f-4664-ad13-a773515ae91a
Source feed: FDA_Inspections

> FDA inspection 1169676 of Akorn Operating Company LLC, May 17, 2022. Classification: Official Action Indicated (OAI). 13 citations under 21 CFR parts 211 and 314. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169676
- Company Name: Akorn Operating Company LLC
- Inspection Date: 2022-05-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 13

## Related Documents

- [FDA Inspection 1064286 - 2018-08-30](https://www.keypedia.com/records/fda_inspections/akorn-operating-company-llc/df13637c-d93c-47a6-8ff6-82a8b2fb4b3c)
- FDA Inspection 1012024 - 2017-05-12
- FDA Inspection 976869 - 2016-04-04
- [FDA Inspection 929221 - 2015-06-05](https://www.keypedia.com/records/fda_inspections/akorn-operating-company-llc/cc7d109f-225c-4aee-814d-f5497cb2db22)
- FDA Inspection 884894 - 2014-05-29

Company: https://www.keypedia.com/companies/akorn-operating-company-llc/347ed7e7-51c4-481b-b84c-3055f99d6288

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
